Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Los Angeles | 4 | 2022 | 647 | 0.56 | Why? |
Quality Assurance, Health Care | 1 | 2017 | 596 | 0.48 | Why? |
Point-of-Care Testing | 3 | 2019 | 2782 | 0.36 | Why? |
Biological Assay | 2 | 2020 | 367 | 0.31 | Why? |
Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.30 | Why? |
Cell Phone | 4 | 2019 | 750 | 0.25 | Why? |
DNA | 2 | 2018 | 778 | 0.23 | Why? |
Diagnostic Techniques and Procedures | 1 | 2022 | 265 | 0.20 | Why? |
Nucleic Acid Amplification Techniques | 3 | 2018 | 3388 | 0.19 | Why? |
Paper | 1 | 2019 | 74 | 0.19 | Why? |
Managed Care Programs | 1 | 2018 | 62 | 0.18 | Why? |
Naphthalenesulfonates | 1 | 2017 | 5 | 0.18 | Why? |
Magnetite Nanoparticles | 1 | 2018 | 109 | 0.17 | Why? |
Intercalating Agents | 1 | 2017 | 49 | 0.17 | Why? |
Point-of-Care Systems | 4 | 2021 | 2955 | 0.16 | Why? |
Microfluidic Analytical Techniques | 1 | 2018 | 254 | 0.15 | Why? |
Saliva | 2 | 2021 | 4679 | 0.14 | Why? |
Printing, Three-Dimensional | 1 | 2020 | 624 | 0.14 | Why? |
Quality Control | 1 | 2017 | 628 | 0.13 | Why? |
Computers, Handheld | 1 | 2015 | 242 | 0.13 | Why? |
Immunoglobulin G | 3 | 2021 | 21571 | 0.11 | Why? |
Serologic Tests | 2 | 2021 | 4359 | 0.10 | Why? |
Perioperative Care | 1 | 2020 | 1329 | 0.10 | Why? |
Academic Medical Centers | 1 | 2020 | 3088 | 0.09 | Why? |
Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
Retrospective Studies | 6 | 2022 | 105322 | 0.08 | Why? |
Early Detection of Cancer | 1 | 2018 | 1956 | 0.08 | Why? |
Quality Improvement | 1 | 2018 | 2435 | 0.07 | Why? |
MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
Colorectal Neoplasms | 1 | 2018 | 1884 | 0.07 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.07 | Why? |
Algorithms | 1 | 2021 | 7346 | 0.06 | Why? |
Reproducibility of Results | 1 | 2020 | 11304 | 0.06 | Why? |
Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
Immunoassay | 1 | 2019 | 4485 | 0.06 | Why? |
Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
Elective Surgical Procedures | 1 | 2020 | 5338 | 0.06 | Why? |
Limit of Detection | 2 | 2021 | 2698 | 0.06 | Why? |
Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 7868 | 0.05 | Why? |
Borrelia burgdorferi | 1 | 2019 | 31 | 0.05 | Why? |
DNA, Neoplasm | 1 | 2018 | 56 | 0.05 | Why? |
Immunochemistry | 1 | 2018 | 95 | 0.05 | Why? |
Emulsions | 1 | 2018 | 80 | 0.05 | Why? |
Reminder Systems | 1 | 2018 | 104 | 0.04 | Why? |
Mass Screening | 1 | 2018 | 8005 | 0.04 | Why? |
Patient Navigation | 1 | 2018 | 62 | 0.04 | Why? |
Bacteriophage lambda | 1 | 2017 | 6 | 0.04 | Why? |
Humans | 16 | 2022 | 930598 | 0.04 | Why? |
Antibodies, Viral | 3 | 2021 | 51949 | 0.04 | Why? |
Lyme Disease | 1 | 2019 | 102 | 0.04 | Why? |
Nucleic Acid Hybridization | 1 | 2017 | 140 | 0.04 | Why? |
Electrochemical Techniques | 1 | 2021 | 406 | 0.04 | Why? |
Oligodeoxyribonucleotides | 1 | 2017 | 206 | 0.04 | Why? |
Antigens | 1 | 2019 | 267 | 0.04 | Why? |
RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
Spectrometry, Fluorescence | 1 | 2017 | 177 | 0.04 | Why? |
Sample Size | 1 | 2018 | 518 | 0.04 | Why? |
Optical Fibers | 1 | 2015 | 35 | 0.04 | Why? |
False Positive Reactions | 1 | 2021 | 1338 | 0.04 | Why? |
Antibodies, Bacterial | 1 | 2019 | 510 | 0.04 | Why? |
Herpes Genitalis | 1 | 2015 | 90 | 0.04 | Why? |
Fluorescence | 1 | 2017 | 475 | 0.04 | Why? |
Gold | 1 | 2019 | 592 | 0.03 | Why? |
Sensitivity and Specificity | 3 | 2021 | 22971 | 0.03 | Why? |
Mumps | 1 | 2015 | 110 | 0.03 | Why? |
California | 1 | 2021 | 2047 | 0.03 | Why? |
Fluorescent Dyes | 1 | 2017 | 536 | 0.03 | Why? |
Herpes Simplex | 1 | 2015 | 272 | 0.03 | Why? |
Colonoscopy | 1 | 2018 | 738 | 0.03 | Why? |
Colorimetry | 1 | 2015 | 458 | 0.03 | Why? |
Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
Metal Nanoparticles | 1 | 2019 | 771 | 0.03 | Why? |
Interdisciplinary Communication | 1 | 2018 | 1425 | 0.03 | Why? |
Appointments and Schedules | 1 | 2018 | 1204 | 0.03 | Why? |
Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
Telephone | 1 | 2018 | 1705 | 0.02 | Why? |
Orthomyxoviridae | 1 | 2017 | 1168 | 0.02 | Why? |
Carrier State | 1 | 2021 | 2100 | 0.02 | Why? |
Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
Patient Education as Topic | 1 | 2018 | 1476 | 0.02 | Why? |
Measles | 1 | 2015 | 608 | 0.02 | Why? |
Equipment Design | 1 | 2018 | 3095 | 0.02 | Why? |
Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
Feces | 1 | 2018 | 4235 | 0.02 | Why? |
Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
United States | 2 | 2021 | 46150 | 0.02 | Why? |
Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
Mobile Applications | 1 | 2015 | 3032 | 0.01 | Why? |
Male | 4 | 2021 | 367725 | 0.01 | Why? |
Aged | 3 | 2021 | 215776 | 0.01 | Why? |
Female | 4 | 2021 | 380317 | 0.01 | Why? |
Machine Learning | 1 | 2015 | 4395 | 0.01 | Why? |
Adult | 3 | 2021 | 244371 | 0.01 | Why? |
Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Garner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(94)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_